Pharma Competitive Intelligence Conference

DAY 1 (Monday, September 15, 2008)

General Session

7:15 – 8:15        Registration & Networking Breakfast in Exhibition Hall

8:15 - 8:30        Chairpersons’ Opening Remarks
                             Daniel Pascheles
                             Vice President, Global Competitive Intelligence
                             Merck

                             Sue Ward
                             Director, Information and Knowledge Management
                             Pfizer

8:30 – 9:15       “Pharma Challenges” Keynote Presentation
                             Wayne Rosenkrans
                             Scientific and Medical Strategy Director
                             AstraZeneca

9:15 – 10:15     “How Does This Change What We Do” Keynote Panel
                             Cliff Kalb (invited)
                             President
                             C.Kalb & Associates, LLC

                             Craig McHenry
                             Senior Director, Competitor Insights
                             Wyeth

                             Daniel Pascheles
                             Vice President, Global Competitive Intelligence
                             Merck

10:15 – 11:10     Networking & Refreshments in Exhibition Hall

11:10 – 11:50     China's Remarkable Economic Growth: Opportunities and Challenges for the
         Pharmaceutical Industry
                              Dr. Linda Yueh
                              Fellow in Economics
                              University of Oxford

11:50 – 12:30     WalMart and You: From Diagnostics to Distribution Are You Doing Enough to Position
         Your Company For 2010?
                              Steve Levy
                              Managing Director
                              Fletcher/CSI, LLC

12:30 – 1:30       Networking Luncheon
         Keynote Presentation:
         Seeing Patterns That Produce Billion Dollar Insights: CI All-Stars Have Learned how to Turn Oceans of
         Data Into Breakthrough Insights.

         This presentation will share field research findings and case examples of how winning CI organizations
         build systems that enable them to convert data into insights and intelligence that inform leadership
         decision-making.
                              Chris Bogan
                              CEO
                              Best Practices

Renee Pierson
Director of Global Business Intelligence
Johnson & Johnson Pharmaceutical Services

Chandra Ramanathan
Director, Global Business and Competitive Intelligence
Bristol-Myers Squibb

Sue Ward
Director, Information & Knowledge Management
Pfizer

Interactive Roundtable Sessions:
Each session will be led by a facilitator who will facilitate the exchange of opinions, sharing of experiences and learning
related to CI. Audience Participation.

1:30 – 2:15

TRACK A TRACK B TRACK C

Outsourcing CI
Bill Sammon
Senior Director of Strategy
Information Analysis
Pfizer

Evaluating Science-Based
Opportunities
Richard Klavans
President
SciTech Strategies

How to Increase CI Productivity and
Effectiveness
Robert Franc
Director of Competitive Intelligence
Centocor

2:15 – 3:00

Web 2.0 Technologies
Francois Bernier
Manager, Strategic Research Planning
Eisai

Competitive Intelligence at
Medical Conventions:
In-Sourcing
Eileen Kelly
Director, Business & Decision Analysis
OSI Pharmaceutical

Information Superiority Using
Mashup Technology Software
Richard Walker
Vice President
Denodo Technologies

Individual Presentations:

3:00 – 3:30

BI/CI in Emerging Markets
(Case Study – BI/CI set-up of a
Chinese Pharma Company)
Holger Meissner
Co-Founder and President
Adler Life Sciences

The Changing World of CI
inside Pharma
Mark Little
Vice President, Business Intelligence &
Market Research
Covance

The Case for Offshore Information
Analysis in a Changing Industry - a
Prudent Strategy for Maximizing the
Return on CI
Rajesh Nair
CEO
Indegene

3:30 – 4:30 Networking & Refreshments in Exhibition Hall

4:30 – 5:30 Panel Discussions

Is There a Balance Between
Strategic CI & Tactical CI?
Deborah Dauber
Group Market Planning Manager
Genentech

Jack Bush
Director, Global Marketing
Intelligence
Alcon Laboratories, Inc.

Monika Giese
Head Global CI
Novartis Pharma AG

J.J. Owen
Associate Director, Scientific &
Competitor Analysis
Millennium Pharmaceuticals

Hari Patel
Associate Director of Business
Intelligence
Bayer HealthCare

Bring Competitive Intelligence
to the Top: Delivering
Intelligence to Executives
Gary McKnight
Director, Information Services
ZymoGenetics, Inc.

Joshua Owolabi
Assistant Director, Discovery &
Assessment Group
TAP

Jeanne Penn
Associate Director, CTI
Genzyme

Shefali Shah
Director of Market Analytics
Exelixis

Medical Devices Special Focus Track:
Challenges in Doing Competitive
Intelligence in the Medical Device
Industry
Included in that discussion will be the
difficulties in obtaining pipeline
information, having limited access to
medical device product information,
shorter product development cycles
compared to Pharma (which results in
more competition coming onboard faster)
Kim Szymanowski
Business Information Worldwide
ETHICON, a Johnson & Johnson company

Additional panelists TBA

5:30 – 9:00 Evening Socializing Events! Speed Dating for Business Development, Casino Gaming, Reception &
Networking

DAY 2 (Tuesday, September 16, 2008)

7:15 – 8:15 Registration & Networking Breakfast in Exhibition Hall

8:15 - 8:30 Chairpersons’ Opening Remarks

8:30 – 9:00

Drugs and Indications:
Matrixing Thought Leaders and
Technology Platforms
Jeffrey D. Berk
President
MedPredict

Pharma CI in Times of
Economic Uncertainty
Erik Glitman
Managing Director
Fletcher/CSI, LLC

9:00 – 10:00

(9:00 – 9:30)
The Third Time is the Charm-
Learnings from Starting a CI
Function Three Times
Mika Partanen (invited)
Associate Director, Global Market
Analytics
Schering-Plough

(9:30 - 10:00)
Post-Small Molecule
Pharmaceuticals: Patent
Analysis and CI for
Combination Therapeutics
Irene Zajac
Analyst
Nerac

Richard Hendricks, PhD
Analyst
Nerac

(9:00 – 10:00)
Career Path of a CI Professional
Marjorie Norman
Manager, Information & Knowledge
Management
Pfizer Global Research &
Development

Kim Szymanowski
Business Information Worldwide
ETHICON, a Johnson & Johnson
company

Friederike Wirtz-Brugger
Senior Manager
Scientific Competitive Intelligence
Sanofi-Aventis

10:00 – 11:00 Networking & Refreshments in Exhibition Hall

11:00 – 12:00

Examining Generic
Developments in the US and EU
Branimir Brankov
Sr. Director Global Competitive Intelligence
Merck

Jerry Hoffman
Manager-Global Competitive
Intelligence Strategy
Eli Lilly & Co.

Susanne Laningham
Director Business Analysis &
Information
Amgen

David Stefanoni
Director, Business Intelligence; Business
Excellent, Analytics & Planning
sanofi-Aventis

Assessing Promotional Strategies
Michael DePeri (invited)
Director of US CI
Roche Laboratories

Thomas Han
Senior Director, Strategic Marketing
Business Analysis
Biovail

Coralie Hughes
Manager, Global Competitive
Intelligence
Eli Lilly & Co.

Eileen Kelly
Director, Business & Decision Analysis
OSI Pharmaceuticals

12:00 – 12:30

International CI – Outsourcing
Primary Research in a Global
Market
Chris Thompson
Managing Director
Navigate International

Competitive Assessment of
Development, Manufacturing,
Regulatory, and (yes)
Promotional Strategies for
Generic Small Molecules and
Biosimilars
Dave Hitchcoff
Vice President Consulting Services
Dunn Group

12:30 – 1:30     Networking Luncheon

General Session

1:30 – 2:00        Topic TBA
                             Martha Matteo (invited)
                             Former President, SCIP, and Former Director,
                             Knowledge Management & R&D Planning,
                             Boehringer Ingelheim

2:00 – 3:00        Bringing Strategic Competitive Insights into New Product Planning & Business Development
           Moderator:
                             Chandra Ramanathan
                             Director, Global Business and Competitive Intelligence
                             Bristol-Myers Squibb

           Panelists:
                             Debbie Allison
                             Senior Director, Global Competitive Intelligence
                             Merck

                             Christian Hein
                             Business Intelligence / Market Research Manager
                             Actelion Pharmaceuticals Ltd

                             Eileen Kelly
                             Director, Business & Decision Analysis
                             OSI Pharmaceuticals

                             Craig McHenry
                             Senior Director, Competitor Insights, Customer & Market Insights
                             Wyeth



3:00 – 3:30        Networking & Refreshments in Exhibition Hall

3:30 – 4:30        Open Session: Bring your Day-to-Day Problems for us to Solve!
                             Robert Franc
                             Director of Competitive Intelligence
                             Centocor

                             Monika Giese
                             Head Global CI
                             Novartis Pharma AG

                             Daniel Pascheles
                             Vice President, Global Competitive Intelligence
                             Merck

                             Chandra Ramanathan
                             Director, Global Business and Competitive Intelligence
                             Bristol-Myers Squibb

                             Sue Ward
                             Director, Information & Knowledge Management
                             Pfizer

4:30 – 5:00        Summary & Attendee Q&A with the Chairpersons
                             Daniel Pascheles
                             Vice President, Global Competitive Intelligence
                             Merck

                             Sue Ward
                             Director, Information & Knowledge Management
                             Pfizer

5:00                   Conference Concludes

DAY 3 (Wednesday, September 17, 2008)

Post Conference Workshops (Separate Registration Required)

8:00 – 12:00      The Wargame Workshop
           Led by Deallus

This workshop is for CI professionals who want to learn more about when and why to run a Wargame as well as how to
execute a successful Wargame. Wargame is a business tool used to improve decision making through role play and rigorous
analysis of the competitive landscape and your own organization’s capabilities and intentions. Decisions are always made
under uncertainty and are therefore based upon assumptions. The participants will leave with a deeper understanding what
is required from a Wargame to ensure your organization reap the most important benefits of a Wargame; identifying,
challenging and improving its assumptions about itself, the competitors, the market and the future.

8:00                   Registration

8:30                   Introduction to Wargaming

9:30                   Designing a Wargame

10:30                 Break

11:00                 Analytical frameworks in Wargaming

12:00                 Q&A

12:30                 Close of Workshop

12:30                 Lunch

1:30 – 5:30        2nd Workshop TBA

TRACK A TRACK B

| Contact Us |

Sheraton at Woodbridge Place
Iselin, New Jersey

September 15-17, 2008

| Back to Top |